Allied Market Research


Metacycline Market

Metacycline Market Size, Share, Competitive Landscape and Trend Analysis Report, by Therapeutics : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Metacycline is a broad spectrum semisynthetic antibiotic that belongs to tetracycline drug class. Esarondil, physiomycine, lysocline, and rotilen are some of the brand names of the antibiotic. Metacycline inhibits protein synthesis and hence cell growth by preventing the binding of aminoacyl transfer RNA to the m-RNA-ribosome complex in the ribosome 30S subunit. The antibiotic is administered in the form of oral tablets.

The wide spectrum of antimicrobial action with the use of metacyclin makes it an active component against gram-positive and gram-negative bacteria. The increase in the incidence of diseases such as rickettsiae, pneumonia, sinusitis, trench fever, and typhus increases the demand for metacycline, which in turn boosts the market growth. Nevertheless, the adverse effects associated with the use of metacycline such as hepatotoxicity, diarrhea, nausea, enterocolitis, and diarrhea hamper the market growth. In addition, the rise in the number of antibiotic resistant organisms and availability of substitutes such as miciclin, monatrex, and muvito also limit the growth of the market.

The global metacycline market is segmented based on application and geography. Based on therapeutics, it is classified into chronic bronchitis, rickettsial infections, pneumonia, trench fever, typhus, Q fever, sinusitis, and others. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as Merck, Boc Sciences, Manus Aktteva Biopharma LLP, Cayman Chemical, Hycultec GmbH, Abcam plc, Santa Cruz Biotechnology, Inc., Hlzel Biotech, Changzhou Pharmaceutical Factory, and The ND Pharma & Biotech Company are also provided in the report.

Key Benefits

  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the global metacycline market.
  • This report entails the detailed quantitative analysis of the current market and estimations¬†which assists in identifying the prevailing market opportunities.
  • The projections in this report are made by analyzing the current trends and future market potential in terms of value.
  • Competitive intelligence (of leading manufacturers and distributors of disposable gloves) helps understand the competitive scenario across the geographies
  • An in-depth analysis of current research and clinical developments within the market is provided with key market dynamic factors that help understand the behavior of the market.

Metacycline Market Report Highlights

Aspects Details
By Therapeutics
  • Chronic bronchitis
  • Rickettsial infections
  • Pneumonia
  • Trench fever
  • Typhus
  • Q fever
  • Sinusitis
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players

The ND Pharma & Biotech Company, Hycultec GmbH, Santa Cruz Biotechnology, Inc., Hlzel Biotech, Cayman Chemical, Manus Aktteva Biopharma LLP, Abcam plc, Boc Sciences, Merck, Changzhou Pharmaceutical Factory

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Metacycline Market

Global Opportunity Analysis and Industry Forecast, 2023-2032